Sutter Health-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Sutter Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013384
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sutter Health (Sutter Health) is a non-profit healthcare service provider, which provides health care service through its hospitals, ambulatory surgery centers, cardiac centers, cancer centers, rehabilitation centers and others. It serves communities across Northern California- in the San Francisco Bay Area, the Central Valley, the Sacramento region and the northern and southern coastal areas. The organization also offers services in other areas, including Hawaii and Southern California. Sutter Health offers carries out transplants, advanced treatments for cancer and surgical techniques and delivery services. Its affiliated and aligned doctors, hospitals and specialty care centers partner to provide patients medical care personalized to their needs. Sutter Health is headquartered in Sacramento, California, the US.

Sutter Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sutter Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sutter Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sutter Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sutter Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sutter Health, Medical Devices Deals, 2011 to YTD 2017 9
Sutter Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sutter Health, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Boehringer Ingelheim Pharma Enters into Research Agreement with Sutter Health 11
AstraZeneca Enters into Research Agreement with Sutter Health 12
Licensing Agreements 13
Insys Therapeutics Enters into Licensing Agreement with California Pacific Medical Center Research Institute 13
Debt Offering 14
Sutter Health Plans Public Offering Of Bonds For US$450 Million 14
Sutter Health Plans Public Offering Of Bonds For US$300 Million 15
Asset Transactions 16
Alameda Health System Completes Acquisition Of San Leandro Hospital From Sutter Health 16
Sutter Health – Key Competitors 17
Sutter Health – Key Employees 18
Sutter Health – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Corporate Communications 21
Oct 25, 2016: Sutter Health to Expand Breast Cancer Services in East Bay with $4 Million Gift 21
Government and Public Interest 22
Nov 22, 2016: Sutter Health receives $1.2 million grant by California Initiative to Advance Precision Medicine 22
Other Significant Developments 23
Oct 17, 2017: Sutter Santa Rosa Regional Hospital to Re-Open Tuesday 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Sutter Health, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Sutter Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sutter Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sutter Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sutter Health, Deals By Therapy Area, 2011 to YTD 2017 8
Sutter Health, Medical Devices Deals, 2011 to YTD 2017 9
Sutter Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Boehringer Ingelheim Pharma Enters into Research Agreement with Sutter Health 11
AstraZeneca Enters into Research Agreement with Sutter Health 12
Insys Therapeutics Enters into Licensing Agreement with California Pacific Medical Center Research Institute 13
Sutter Health Plans Public Offering Of Bonds For US$450 Million 14
Sutter Health Plans Public Offering Of Bonds For US$300 Million 15
Alameda Health System Completes Acquisition Of San Leandro Hospital From Sutter Health 16
Sutter Health, Key Competitors 17
Sutter Health, Key Employees 18
Sutter Health, Subsidiaries 19

★海外企業調査レポート[Sutter Health-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Capture Vascular Inc:医療機器:M&Aディール及び事業提携情報
    Summary Capture Vascular Inc (Capture Vascular) is a medical device development company that develops and commercializes mechanical thrombectomy systems. The company offers MegaVac, a mechanical thrombectomy system that removes clots in arteries and provides vessel occlusion, embolic prevention and …
  • Sharps Compliance Corp (SMED):企業の財務・戦略的SWOT分析
    Summary Sharps Compliance Corp (Sharps) is a healthcare waste solution company that offers regulatory compliant services. The company offers products such as sharps disposal systems, public sharps safety, takeaway medication recovery system, collection and disposal system, complete needle collection …
  • Central and North West London NHS Foundation Trust:企業の戦略的SWOT分析
    Central and North West London NHS Foundation Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compet …
  • PriceSmart, Inc.:企業の戦略・SWOT・財務分析
    PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report Summary PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • NEC Networks & System Integration Corp (1973):企業の財務・戦略的SWOT分析
    NEC Networks & System Integration Corp (1973) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Theravance Biopharma Inc (TBPH):企業の財務・戦略的SWOT分析
    Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Jackson Electric Membership Corp:企業の戦略的SWOT分析
    Jackson Electric Membership Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Icade SA:企業のM&A・事業提携・投資動向
    Icade SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Icade SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • TriVascular Inc:製品パイプライン分析
    Summary TriVascular Inc (TriVascular), a subsidiary of Endologix Inc is a medical device company that researches, designs and manufactures technologies to provide optimal solutions for endovascular aortic repair. The company’s product comprise endovascular grafts and self-expanding stent grafts; ova …
  • Oil & Gas Development Co Ltd (OGDC):石油・ガス:M&Aディール及び事業提携情報
    Summary Oil & Gas Development Co Ltd (OGDCL) is an integrated upstream oil and gas company. It explores, develops and produces oil and gas from its assets in the provinces of Punjab, Sindh, Balochistan, and Kyber Pakhtoon Khawa (KPK) in Pakistan. OGDCL owns interests in operated and non-operated exp …
  • PositiveID Corp (PSID):企業の財務・戦略的SWOT分析
    Summary PositiveID Corp (PositiveID), formerly VeriChip Corp is a life sciences tools and diagnostics company that develops biological detection and molecular diagnostic systems. The company develops microfluidic systems for automated preparation and performance of biological assays. Its products in …
  • SCHOTT AG:戦略・SWOT・企業財務分析
    SCHOTT AG - Strategy, SWOT and Corporate Finance Report Summary SCHOTT AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Boart Longyear Ltd:企業の戦略・SWOT・財務情報
    Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report Summary Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • UNIQA Biztosito Zrt.:企業の戦略・SWOT・財務情報
    UNIQA Biztosito Zrt. - Strategy, SWOT and Corporate Finance Report Summary UNIQA Biztosito Zrt. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PureCircle Ltd:企業の戦略・SWOT・財務情報
    PureCircle Ltd - Strategy, SWOT and Corporate Finance Report Summary PureCircle Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Fauji Fertilizer Co Ltd (FFC):企業の財務・戦略的SWOT分析
    Fauji Fertilizer Co Ltd (FFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Service Corporation International (SCI):企業の財務・戦略的SWOT分析
    Service Corporation International (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Nature’s Sunshine Products Inc (NATR):企業の財務・戦略的SWOT分析
    Summary Nature's Sunshine Products Inc (Nature's Sunshine) is a manufacturer and marketer of nutritional and personal care products. The company’s products comprise daily essential pack, probiotics, antioxidants, enzymes, vitamins and minerals, general cleansers, fiber, meal replacement and protein, …
  • Physiomics Plc (PYC):製薬・医療:M&Aディール及び事業提携情報
    Summary Physiomics plc (Physiomics) is a computational systems biology services company. It offers Virtual Tumour, which optimizes the dosing and scheduling of oncology drugs in pre-clinical trials, cardiac toxicity services through its EasyAP, a Web-based simulation and analysis tool. It also offer …
  • Hepion Pharmaceuticals Inc (HEPA):企業の財務・戦略的SWOT分析
    Summary Hepion Pharmaceuticals Inc (Hepion) formerly known as ContraVir Pharmaceuticals Inc, is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV4 …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆